Monday, 20 May 2019

RA/Inflammatory arthritis

Datesort ascending Type Title Save
05 Dec 2018 News PRAIRI Study - Can RA Be Prevented?
05 Dec 2018 Social CARRA reports it has completed enrollment of 403 newly diagnosed polyarticular JIA patients in STOP-JIA (Start Time Optimization of Biologic Therapy in Polyarticular JIA). Results anticipated in late 2019. https://t.co/V2qvZCRXvs
05 Dec 2018 Social Interdisciplinary guidelines for treating Uveitis in JIA - 1) Topical steroids; 2) if not improved, MTX; 3) Then TNF inhibitor; 4) systemic steroids; or 5) other biologics (TCZ, ABA, RTX). https://t.co/6D1aq3xQqA
04 Dec 2018 Social Cohort study 56866 RA/PsA/AS patients compared 287 w/ multiple myeloma & 2760 matched controls - no difference in MM risk related to biologic, DMARD or NSAIDs. But compared to DMARD only pts, Biologic + DMARD users had a 48% lower risk of MM (OR 0.52) https://t.co/DsmvNXC9c9
02 Dec 2018 Social FDA has approved Genentechs ACTpen - a tocilizumab autoinjector 162 mg sc for use in RA, GCA, poly and systemic JIA - should be available in January 2019. https://t.co/YzFHyYxQlS
02 Dec 2018 Social Study of 2053 RA patients from VA medical centers found 27% with chronic lung disease that confered a 51% increased mortality risk; sadly this was not altered by MTX or biologic therapy. https://t.co/nYFnScSXQ4
29 Nov 2018 News Rheumatoid Lung Disease Imposes Significant Morbidity and Mortality
29 Nov 2018 Social Study of 2053 RA patients from VA medical centers found 27% with chronic lung disease that confered a 51% increased mortality risk that was not altered by MTX or biologic therapy. https://t.co/nYFnScSXQ4
29 Nov 2018 Social FDA has approved Genentechs ACTpen - a tocilizumab autoinjector 162 mg sc for use in RA, GCA, poly & systemic JIA - should be available in January 2019. https://t.co/YzFHyYxQlS
28 Nov 2018 Social A systematic literature review shows that triple positivity for ACPAs, RF, and anti‐CarP antibodies yields a higher specificity for RA (98–100%), accompanied by a lower sensitivity (11–39%). https://t.co/TKAZd7CP1M
26 Nov 2018 Slide of the day ESR & Age
21 Nov 2018 Social The Next Best Meeting in Rheumatology is coming - RHEUMNOW LIVE - March 22-24 2019 in beautiful downtown Fort Worth. Short Lectures, interactive sessions, Q&A panels, TED (like) Talks, digital, streaming and much more. You dont want to miss this meeting! https://t.co/5TVg0Frsbf
21 Nov 2018 Social Large claims analysis shows that lipid screening was suboptimal (37%) among RA patients but was higher when RA patients visited a rheumatologist and a non-rheumatology clinicians (~55%). https://t.co/S4Op22LOoY
20 Nov 2018 Social J Rheum (Ward et al) reports that the minimal clinically important improvement (MCII) of RAPID-3 was –3.8. https://t.co/UxCOeMl52g
16 Nov 2018 Social 44 WF w/ RA is on max dose MTX + ETN for 7 mos. but still has 5 swollen joints, CDAI =13 & nl ESR/CRP. What do you do next?
15 Nov 2018 News Growing Tick Population Comes with Health Concerns
14 Nov 2018 News Chikungunya Virus Vaccine Developed
14 Nov 2018 Social CCP+ RA patient starts out with 8 tender, 6 swollen and DAS=5.1. Put on MTX and TNFi and quickly goes into remission (0 joints) at month 6, 12, 18. At next visit what do you do w/ meds?
13 Nov 2018 News Subclinical Heart Inflammation Seen in RA
12 Nov 2018 Social Metanalysis of 10 studies and 204 RA patients suggests that during pregnancy disease activity improved in 60% of patients but flared post-partum in nearly half (47%). https://t.co/DHeY4rgKu1